Literature DB >> 19131637

Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis.

Michael Y Tsai1, Na Li, A Richey Sharrett, Steven Shea, David R Jacobs, Russell Tracy, Donna Arnett, Valerie Arends, Wendy Post.   

Abstract

BACKGROUND: ATP-binding cassette A1 (ABCA1) and cholesteryl ester transfer protein (CETP) play important roles in the reverse cholesterol transport pathway. The associations of ABCA1 and CETP polymorphisms with lipoprotein subclasses have not been extensively studied.
METHODS: We genotyped 2 ABCA1 and 5 CETP polymorphisms in 999 participants of the Multi-Ethnic Study of Atherosclerosis (MESA) and studied their associations with HDL and LDL subclass particle concentrations, measured by nuclear magnetic resonance spectroscopy.
RESULTS: ABCA1 and CETP polymorphisms were associated with different and distinct changes in lipoprotein subclass concentrations. The ABCA1 1051G/A AA genotype, previously found to be associated with cardioprotective effects in this cohort, was associated with a 5.5% higher concentration of small HDL particles (P = 0.024). The CETP TaqIB B2B2, -2505C/A AA, and -629C/A AA genotypes, previously demonstrated to lack cardioprotective effects, were associated with 15.2%, 15.4%, and 11.7% higher HDL cholesterol concentrations, respectively, and 36.5%, 40.7%, and 25.4% higher large HDL particle concentrations (P < 0.0001). The minor alleles of the A373P and R451Q polymorphisms were associated with lower large HDL particle concentrations.
CONCLUSIONS: Our study of the influence of ABCA1 and CETP genetic variants on lipoprotein subclasses demonstrates the importance of interpreting lipoprotein subclasses within the context of the biochemical processes involved in the alterations. In the case of HDL, the study of subclass particle numbers and sizes may not be sufficiently informative. Assays for HDL function may be needed to supplement quantification of HDL cholesterol and HDL particle numbers and sizes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131637      PMCID: PMC5785275          DOI: 10.1373/clinchem.2008.107995

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  38 in total

1.  Association between well-characterized lipoprotein-related genetic variants and carotid intimal medial thickness and stenosis: The Framingham Heart Study.

Authors:  Roberto Elosua; L Adrienne Cupples; Caroline S Fox; Joseph F Polak; Ralph A D'Agostino; Philip A Wolf; Christopher J O'Donnell; Jose M Ordovas
Journal:  Atherosclerosis       Date:  2006-01-23       Impact factor: 5.162

2.  Associations between two common polymorphisms in the ABCA1 gene and subclinical atherosclerosis: Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Jeana L Benton; Jingzhong Ding; Michael Y Tsai; Steven Shea; Jerome I Rotter; Gregory L Burke; Wendy Post
Journal:  Atherosclerosis       Date:  2006-08-01       Impact factor: 5.162

3.  High density lipoprotein cholesterol and mortality. The Framingham Heart Study.

Authors:  P W Wilson; R D Abbott; W P Castelli
Journal:  Arteriosclerosis       Date:  1988 Nov-Dec

4.  Pre beta 1-high-density lipoprotein increases in coronary artery disease.

Authors:  T Miida; Y Nakamura; K Inano; T Matsuto; T Yamaguchi; T Tsuda; M Okada
Journal:  Clin Chem       Date:  1996-12       Impact factor: 8.327

5.  Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study.

Authors:  B Agerholm-Larsen; A Tybjaerg-Hansen; P Schnohr; R Steffensen; B G Nordestgaard
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

6.  Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism.

Authors:  Hong Lu; Akihiro Inazu; Yuri Moriyama; Toshinori Higashikata; Masa-Aki Kawashiri; Wenxin Yu; Zhiping Huang; Tomonori Okamura; Hiroshi Mabuchi
Journal:  J Mol Med (Berl)       Date:  2003-03-26       Impact factor: 4.599

7.  Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men.

Authors:  M A Austin; B L Rodriguez; B McKnight; M J McNeely; K L Edwards; J D Curb; D S Sharp
Journal:  Am J Cardiol       Date:  2000-08-15       Impact factor: 2.778

8.  High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.

Authors:  J Johansson; L A Carlson; C Landou; A Hamsten
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb

9.  Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

Authors:  Michiel L Bots; Frank L Visseren; Gregory W Evans; Ward A Riley; James H Revkin; Charles H Tegeler; Charles L Shear; William T Duggan; Ralph M Vicari; Diederick E Grobbee; John J Kastelein
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321

10.  The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.

Authors:  Urbain Tchoua; Wilissa D'Souza; Nigora Mukhamedova; Denise Blum; Eric Niesor; Jacques Mizrahi; Cyrille Maugeais; Dmitri Sviridov
Journal:  Cardiovasc Res       Date:  2007-12-04       Impact factor: 10.787

View more
  7 in total

1.  Effect of fenofibrate therapy and ABCA1 polymorphisms on high-density lipoprotein subclasses in the Genetics of Lipid Lowering Drugs and Diet Network.

Authors:  Michael Y Tsai; Jose M Ordovas; Na Li; Robert J Straka; Naomi Q Hanson; Valerie L Arends; Donna Arnett
Journal:  Mol Genet Metab       Date:  2010-03-06       Impact factor: 4.797

2.  Are centenarians genetically predisposed to lower disease risk?

Authors:  Jonatan R Ruiz; Carmen Fiuza-Luces; Amaya Buxens; Amalia Cano-Nieto; Félix Gómez-Gallego; Catalina Santiago; Gabriel Rodríguez-Romo; Nuria Garatachea; José I Lao; María Morán; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2011-09-06

3.  Cholesteryl ester transfer protein gene polymorphisms and longevity syndrome.

Authors:  Genovefa Kolovou; Marianna Stamatelatou; Katherine Anagnostopoulou; Peggy Kostakou; Vana Kolovou; Constantinos Mihas; Ioannis Vasiliadis; Olga Diakoumakou; Dimitri P Mikhailidis; Dennis V Cokkinos
Journal:  Open Cardiovasc Med J       Date:  2010-01-29

Review 4.  We are ageing.

Authors:  Genovefa D Kolovou; Vana Kolovou; Sophie Mavrogeni
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

5.  Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.

Authors:  Zhijie Xiao; Juan Wang; Weirong Chen; Peng Wang; Houlin Zeng; Weixi Chen
Journal:  Lipids Health Dis       Date:  2012-11-26       Impact factor: 3.876

6.  Interaction of cholesterol ester transfer protein polymorphisms, body mass index, and birth weight with the risk of dyslipidemia in children and adolescents: the CASPIAN-III study.

Authors:  Motahar Heidari-Beni; Roya Kelishadi; Marjan Mansourian; Gholamreza Askari
Journal:  Iran J Basic Med Sci       Date:  2015-11       Impact factor: 2.699

7.  Logic Regression Analysis of Gene Polymorphisms and HDL Levels in a Nationally Representative Sample of Iranian Adolescents: The CASPIAN-III Study.

Authors:  Mehri Moghadasi; Roya Kelishadi; Hamid Reza Marateb; Shaghayegh Haghjooy Javanmard; Marjan Mansourian; Ramin Heshmat; Mohammad Esmaeil Motlagh
Journal:  Int J Endocrinol Metab       Date:  2017-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.